title: Is nuclear factor erythroid 2-related factor 2 responsible for sex differences in susceptibility to acetaminophen-induced hepatotoxicity in mice?
abstract: Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor that positively regulates the expression and activity of cytoprotective genes during periods of oxidative stress. It has previously been shown that some Nrf2 genes are more highly expressed in livers of female than male mice. This could explain previously reported sex-related differences in susceptibility to acetaminophen (APAP) hepatotoxicity in mice, where females show greater resistance to APAP hepatotoxicity. Here, we examined, for the first time, differences in mRNA and protein expression for Nrf2 and a battery of Nrf2-dependent genes in naïve wild-type (WT) and overnight-fasted WT and Nrf2-null male and female mice following APAP treatment. Alanine aminotransferase (ALT) activity was measured as an indicator of hepatotoxicity. Hepatic mRNA and protein levels were measured by quantitative polymerase chain reaction and western blotting, respectively. Contrary to expectations, basal Nrf2 mRNA and protein expression were significantly lower in livers of naïve female than male mice. Although mRNA and/or protein expression of quinone oxidoreductase 1 and multidrug resistance-associated protein 4 was more pronounced in livers of female than male mice under some of the conditions examined, no higher global expression of Nrf2-dependent genes was detected in female mice. Furthermore, ALT activity was significantly elevated in overnight-fasted WT and Nrf2-null male mice following APAP treatment, but no increases in ALT were observed in either genotype of female mice. These results indicate that factors other than Nrf2 are responsible for the lower susceptibility of female mice to APAP hepatotoxicity.
authors.affiliation: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (P.R.R., S.R., J.E.M.); and Office of Translational Science, Rutgers University, Piscataway, New Jersey (M.J.G.).
authors.forename: Philip R
authors.initials: PR
authors.lastname: Rohrer
authors.affiliation: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (P.R.R., S.R., J.E.M.); and Office of Translational Science, Rutgers University, Piscataway, New Jersey (M.J.G.).
authors.forename: Swetha
authors.initials: S
authors.lastname: Rudraiah
authors.affiliation: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (P.R.R., S.R., J.E.M.); and Office of Translational Science, Rutgers University, Piscataway, New Jersey (M.J.G.).
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Goedken
authors.affiliation: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut (P.R.R., S.R., J.E.M.); and Office of Translational Science, Rutgers University, Piscataway, New Jersey (M.J.G.) jose.manautou@uconn.edu.
authors.forename: José E
authors.initials: JE
authors.lastname: Manautou
mesh_terms: D000082:Acetaminophen / Q000009:adverse effects*; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism*; D005215:Fasting; D005260:Female; D005978:Glutathione / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000096:biosynthesis; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000096:biosynthesis; D051267:NF-E2-Related Factor 2 / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D012727:Sex Characteristics
chemical_list: D000082:Acetaminophen; D000410:Alanine Transaminase; D005978:Glutathione; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D016660:NAD(P)H Dehydrogenase (Quinone); D051267:NF-E2-Related Factor 2
references.citation: Toxicol Appl Pharmacol. 2012 Nov 1;264(3):387-94
references.pmid: 22980195
references.citation: Toxicol Sci. 2006 Feb;89(2):370-9
references.pmid: 16177239
references.citation: Proc Natl Acad Sci U S A. 1984 Mar;81(5):1327-31
references.pmid: 6424115
references.citation: Life Sci. 2001 Nov 9;69(25-26):3113-9
references.pmid: 11758836
references.citation: Hepatology. 2010 Dec;52(6):2065-76
references.pmid: 20949552
references.citation: Nat Protoc. 2006;1(6):3159-65
references.pmid: 17406579
references.citation: Proteomics. 2003 Feb;3(2):191-207
references.pmid: 12601812
references.citation: Toxicol Appl Pharmacol. 1994 Dec;129(2):252-63
references.pmid: 7992315
references.citation: Genes Dev. 1999 Jan 1;13(1):76-86
references.pmid: 9887101
references.citation: Hepatology. 2004 May;39(5):1267-76
references.pmid: 15122755
references.citation: Toxicol Appl Pharmacol. 1995 Feb;130(2):257-71
references.pmid: 7871539
references.citation: J Biol Chem. 2003 Jun 20;278(25):22243-9
references.pmid: 12646564
references.citation: Toxicol Sci. 2006 Jan;89(1):31-41
references.pmid: 16177235
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2046-51
references.pmid: 14764898
references.citation: PLoS One. 2013;8(4):e61186
references.pmid: 23577207
references.citation: Toxicol Appl Pharmacol. 2008 Jan 1;226(1):74-83
references.pmid: 17935745
references.citation: Hepatology. 2005 Dec;42(6):1364-72
references.pmid: 16317692
references.citation: J Clin Pharm Ther. 1999 Feb;24(1):7-16
references.pmid: 10319902
references.citation: Arch Pharm Res. 1994 Apr;17(2):109-14
references.pmid: 10319141
references.citation: Toxicol Sci. 2005 Jan;83(1):44-52
references.pmid: 15496496
references.citation: Toxicology. 2011 Sep 5;287(1-3):54-60
references.pmid: 21672600
references.citation: Toxicol Pathol. 2007 Jun;35(4):459-73
references.pmid: 17562481
references.citation: Annu Rev Pharmacol Toxicol. 2003;43:233-60
references.pmid: 12359864
references.citation: Steroids. 2011 Jan;76(1-2):118-24
references.pmid: 20933533
references.citation: Toxicol Sci. 2006 Jul;92(1):33-41
references.pmid: 16611625
references.citation: Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12741-5
references.pmid: 11058152
references.citation: Toxicol Sci. 2001 Jan;59(1):169-77
references.pmid: 11134556
references.citation: J Intern Med. 2007 Sep;262(3):393-401
references.pmid: 17697161
references.citation: PLoS One. 2013;8(3):e59122
references.pmid: 23527105
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4611-6
references.pmid: 11287661
references.citation: Pharmacol Rev. 2003 Jun;55(2):229-40
references.pmid: 12773628
references.citation: Drug Discov Ther. 2013 Apr;7(2):78-83
references.pmid: 23715506
references.citation: N Engl J Med. 2008 Jul 17;359(3):285-92
references.pmid: 18635433
references.citation: Toxicol Sci. 2007 Oct;99(2):628-36
references.pmid: 17584759
references.citation: Drug Metab Dispos. 2003 Jun;31(6):798-804
references.pmid: 12756215
references.citation: Curr Drug Metab. 2005 Aug;6(4):309-28
references.pmid: 16101571